WARREN, N.J. — August 8, 2025 — Leads & Copy — Tevogen Bio Holdings Inc. (Nasdaq: TVGN) announced an update on institutional ownership of the company’s outstanding common stock, as reported by institutional investment managers on Form 13F filed with the Securities and Exchange Commission (SEC).
Institutional ownership of Tevogen common stock increased by 60% compared to the reported amount on December 31, 2024, as reported on March 31, 2025. Vanguard and BlackRock increased their holdings by 151%, and 73% of the 51 institutional investment managers holding Tevogen stock as reported on March 31, 2025, increased or maintained their positions.
Tevogen’s Head of Investor Relations, Tapan Shah, said that increased institutional ownership is a sign of confidence in a company’s fundamentals and long-term growth potential. The company will provide another institutional ownership update following the next SEC reporting period.
Contact:
Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701
Communications@Tevogen.com
Source: Tevogen Bio Holdings Inc.
